EXOZ
EXOZYMES INC.
NASDAQ · Healthcare · Biotechnology · US
$6.44
+3.96%Price chart
Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18
Key dataSep 18, 2026
Open$6.17
From 52W high−61.00%
Volume16334.00
Market cap$59.73M
P/E (TTM)—
P/S (TTM)—
Div yield—
Key dataSep 18, 2026
Open
$6.17
From 52W high
−61.00%
Volume
16334.00
Market cap
$59.73M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−5.2x
P/E (TTM)
—
RSI (14)
52.8
MomentumView details →
1D Return
+3.96%
YTD Return
−39.63%
SummaryUpdated Jun 1, 2026
eXoZymes, Inc. (NASDAQ:EXOZ) is a synthetic biochemical company founded in 2014 and headquartered in Monrovia, California. The company went public in November 2024, representing a relatively new entrant to the public markets in the biotechnology sector. eXoZymes focuses on developing platform technologies for producing various chemicals through biological processes, positioning itself at the intersection of biotechnology and industrial chemistry.
Similar companies
Latest newsMore news →
eXoZymes Inc. announced an agreement with Curia Global, Inc. to initiate commercial-scale manufacturing of its NCT product, with the program expected to commence in Q4 2026 and a roadmap for larger-scale production in 2027.12d agoeXoZymes announced that its optimized NCT process achieved a 10-fold productivity increase, advancing beyond original commercial-scale economic targets.33d agoeXoZymes was selected by the U.S. Department of Energy for the Genesis Mission to collaborate with Lawrence Berkeley National Laboratory on AI-powered digital twins for cell-free biomanufacturing, with total funding of approximately $747,000 including $147,000 awarded to eXoZymes.59d ago